The six approved drugs include bortezomib, cisplatin, doxorubicin, docetaxel, fluorouracil, and paclitaxel, which are crucial for the treatment of cancer.

India: Venus Remedies has obtained marketing authorization from the Philippines, the second-largest market in the ASEAN region, for six essential chemotherapy medications, with this, Venus Remedies has secured 525 marketing approvals for its oncology products across 76 countries. The company has obtained marketing approval for 52 products in different market sectors, which offers significant prospects for the company to broaden its presence in the Asia Pacific region as a whole, with a particular focus on Southeast Asia, acknowledgements to its extensive range of pharmaceuticals.

 Venus Remedies Ltd witnessed an increase of 18.15 percent in its share price following the company's announcement of receiving marketing approval. Venus Remedies has already furnished dossiers to the Health Ministry of the Philippines government, seeking approval for an additional 45 marketing authorizations. While pursuing its growth initiatives in the ASEAN region, the company's oncology division has successfully obtained marketing approval for the chemotherapy drug oxaliplatin in Myanmar. This achievement comes three months after Venus Remedies received marketing authorization in Malaysia, one of Southeast Asia's largest pharmaceutical markets, for another chemotherapy medication, pemetrexed. Additionally, the company has now acquired product registration for an alternative dosage of the same drug. Venus Remedies' oncology products enjoy significant utilization in prominent chemotherapy centers in Malaysia, such as Onco Life.

According to the Chief Executive Officer of Venus Medicine Research Centre, “While oncology drugs account for 157 of our 205 marketing authorizations in the ASEAN region, we are banking on these product registrations from the Philippines to pave the way for faster approval of these drugs in other Southeast Asian countries as well. Consequently, we will further expand our operations to other ASEAN markets, reaffirming our commitment to provide advanced cancer treatment options with improved outcomes for patients.”

According to TechSci Research, Chemotherapy is a widely used cancer treatment that involves the use of specialized medications to combat and manage the growth of cancer cells. Chemotherapy medications are a diverse group of drugs designed to target cancer cells and impede their growth or destroy them entirely. These medications can be administered in various ways, including oral pills, intravenous (IV) infusions, injections, and topical creams. The choice of chemotherapy medication, as well as the route of administration, depends on the type of cancer, its stage, and the patient's overall health. The primary goal of chemotherapy is to disrupt the division and growth of cancer cells. Unlike targeted therapies that specifically attack cancer cells, chemotherapy drugs affect both healthy and cancerous cells, leading to certain side effects.